Interestingly, of these four antibodies, the two featuring the bad control VHH, targeted against mouse EGFR, (CV19B265 and CV19B289) displayed off-rates of binding ~5-collapse faster than the mAbs and the bifunctional molecules featuring VHH2 (CV19B277 and CV19B283)

Interestingly, of these four antibodies, the two featuring the bad control VHH, targeted against mouse EGFR, (CV19B265 and CV19B289) displayed off-rates of binding ~5-collapse faster than the mAbs and the bifunctional molecules featuring VHH2 (CV19B277 and CV19B283). this design is

This observation is somewhat paradoxical considering that increased antibodies are connected with better survival in other studies (24, 25) and that people observed significantly improved PFS and OS in those patients who demonstrated a rise in HER2-specific antibody responses while on treatment

This observation is somewhat paradoxical considering that increased antibodies are connected with better survival in other studies (24, 25) and that people observed significantly improved PFS and OS in those patients who demonstrated a rise in HER2-specific antibody responses while